CIK 0001680367 · Non-accelerated filer<br>Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812575858
- Phone
- 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-21 | Gibson Neil W Director | Grant or award · Stock Option (Right to Buy) | +27,700 | 27,700 | ||
| 2024-06-21 | Boudreau Helen M Director | Grant or award · Stock Option (Right to Buy) | +27,700 | 27,700 | ||
| 2024-06-21 | Brownstein Carrie Director | Grant or award · Stock Option (Right to Buy) | +27,700 | 27,700 | ||
| 2024-06-21 | Brous Tyler Director | Grant or award · Stock Option (Right to Buy) | +27,700 | 27,700 | ||
| 2024-06-04 | Schreiber Taylor Chief Executive Officer | Option exercise | +3,050 | $3.57 | $11K | 20,102 |
| 2024-06-04 | Schreiber Taylor Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −3,050 | 162,000 | ||
| 2024-05-10 | Stout Stephen See Remarks | Shares withheld for taxes | −967 | $10.42 | $10K | 73,470 |
| 2024-03-28 | Redmile Group, LLC Director | Other disposition | −4,425 | 5,615,489 | ||
| 2024-03-06 | Stout Stephen See Remarks | Option exercise 10b5-1 | +4,650 | $3.51 | $16K | 83,982 |
| 2024-03-06 | Stout Stephen See Remarks | Sale 10b5-1 | −4,650 | $10.53 | $49K | 79,332 |
| 2024-03-06 | Stout Stephen See Remarks | Option exercise 10b5-1 | +6,459 | $3.57 | $23K | 85,791 |
| 2024-03-06 | Stout Stephen See Remarks | Sale 10b5-1 | −6,459 | $10.53 | $68K | 79,332 |
| 2024-03-06 | Stout Stephen See Remarks | Sale 10b5-1 | −4,895 | $10.53 | $52K | 74,437 |
| 2024-03-06 | Stout Stephen See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,650 | 9,300 | ||
| 2024-03-06 | Stout Stephen See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,459 | 17,391 | ||
| 2024-03-06 | SIEGALL CLAY B Director | Grant or award · Stock Option (Right to Buy) | +33,409 | 33,409 | ||
| 2024-03-06 | Sasser Amy Kate Director | Grant or award · Stock Option (Right to Buy) | +33,409 | 33,409 | ||
| 2024-01-30 | Pandite Arundathy N. Chief Medical Officer | Shares withheld for taxes | −2,920 | $9.99 | $29K | 216,360 |
| 2024-01-30 | Stout Stephen See Remarks | Shares withheld for taxes | −593 | $9.99 | $6K | 79,332 |
| 2024-01-30 | Shukla Abhinav A. Chief Technical Officer | Shares withheld for taxes | −2,290 | $9.99 | $23K | 79,427 |
Page 7 of 7 · 140 trades